» Articles » PMID: 33734524

Benefits and potential harms of COVID-19 Vaccination During Pregnancy: Evidence Summary for Patient Counseling

Overview
Date 2021 Mar 18
PMID 33734524
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Scrutinizing the COVID-19 vaccine safety debate.

Bin Abdulrahman K, Bin Abdulrahman A Hum Vaccin Immunother. 2024; 20(1):2401646.

PMID: 39693192 PMC: 11540079. DOI: 10.1080/21645515.2024.2401646.


COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales.

Gu X, Agrawal U, Midgley W, Bedston S, Anand S, Goudie R NPJ Vaccines. 2024; 9(1):147.

PMID: 39143081 PMC: 11324884. DOI: 10.1038/s41541-024-00934-9.


Awareness and Safety of COVID-19 Vaccination in Pregnancy.

Shree P, Verma V, Patel N, Gupta R, Yadav K J Obstet Gynaecol India. 2024; 74(2):119-124.

PMID: 38707885 PMC: 11065851. DOI: 10.1007/s13224-023-01918-w.


Perinatal outcomes and sinopharm BBIBP-CorV vaccination during pregnancy.

Hatami D, Habibelahi A, Changizi N, Heidarzadeh M, Nojomi M, Rast M BMC Pregnancy Childbirth. 2024; 24(1):190.

PMID: 38468216 PMC: 10926583. DOI: 10.1186/s12884-024-06389-z.


Description of maternal and neonatal adverse events in pregnant people immunised with COVID-19 vaccines during pregnancy in the CLAP NETWORK of sentinel sites. Nested case-control analysis of the immunization-associated risk: A study protocol.

Saint-Gerons D, Castro J, Colomar M, Rojas E, Sosa C, Ropero A BMJ Open. 2024; 14(1):e073095.

PMID: 38286697 PMC: 10826566. DOI: 10.1136/bmjopen-2023-073095.


References
1.
Voysey M, Clemens S, Madhi S, Weckx L, Folegatti P, Aley P . Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020; 397(10269):99-111. PMC: 7723445. DOI: 10.1016/S0140-6736(20)32661-1. View

2.
Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I . Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021; 9(6):e759-e772. PMC: 8012052. DOI: 10.1016/S2214-109X(21)00079-6. View

3.
Richner J, Himansu S, Dowd K, Butler S, Salazar V, Fox J . Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 2017; 168(6):1114-1125.e10. PMC: 5388441. DOI: 10.1016/j.cell.2017.02.017. View

4.
Herberts C, Melgert B, van der Laan J, Faas M . New adjuvanted vaccines in pregnancy: what is known about their safety?. Expert Rev Vaccines. 2010; 9(12):1411-22. DOI: 10.1586/erv.10.133. View

5.
Larocca R, Mendes E, Abbink P, Peterson R, Martinot A, Iampietro M . Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR Mice. Cell Host Microbe. 2019; 26(5):591-600.e4. PMC: 6863051. DOI: 10.1016/j.chom.2019.10.001. View